Tumores cultivados en chips permiten identificar si las células de cáncer de mama de un paciente son sensibles o resistentes a tratamientos.

Tumor-on-chip as a personalized platform for rapid drug testing in breast cancer Clara Helal1,2,9 ∙ Léa Pinon1,9 ∙ Juliette Jin1,9 ∙ … ∙ Maria Carla Parrini3 Send email to maria-carla.parrini@curie.fr ∙ Luc Cabel2 Send email to luc.cabel@curie.fr ∙ Stéphanie Descroix https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(26)00428-3?utm_medium=email&_hsenc=p2ANqtz--daNrghW4o2Omjrl23BcTQ2FShhpD0kfZJzsQcHUBHJtbR7lYdgOOyyp0Y9z281oEIAjbGD0s3y1AM7MNCZkjgsEA7VA&_hsmi=144840094&utm_content=144848639&utm_source=hs_email